Advanced search
Publication Cover
Journal of Nutritional & Environmental Medicine Volume 12, 2002 - Issue 3
Journal homepage
7
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Milk Xanthine Oxidase: Hazard or Benefit?

Roger Harrison Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK
Pages 231-238 | Published online: 13 Jul 2009

  • Patton S, Keenan TW. The milk fat globule membrane. Biochem Biophys Acta 1975; 415: 273-309.
  • Keenan TW, Patton S. The structure of milk: implications for sampling and storage. A. The milk lipid globule membrane. In: Jensen RG (ed.) Handbook of Milk Composition. New York: Academic Press, 1995: 5-50.
  • Bray RC. Molybdenum iron sulfur flavin hydroxylases and related enzymes. In: Boyer PD (ed.) The Enzymes. New York: Academic Press, 1975: 299-419.
  • Hille R. The mononuclear molybdenum enzymes. Chem Rev 1996; 96: 2757-816.
  • McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 12: 159-63.
  • Finkel T. Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukocyte Biol 1999; 65: 337-40.
  • Harrison R. Xanthine oxidoreductase. In: Winyard PG, Blake DR, Evans CH (eds) Free Radicals and Inflammation. Basle: Birkhauser, 2000: 65-81.
  • Hancock JT, Desikan R, Neill SJ. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 2001 ; 29: 345-50.
  • Davies DF. Immunology of human atheroma. In: Freed DLJ (ed.) Health Hazards of Milk. London: Balliere-Tindall, 1984: 201-12.
  • Davies DF, Davies JR, Richards MA. Antibodies to reconstituted dried milk protein in coronary heart disease. J Atheroscler Res 1969; 9: 103-7.
  • Davies DF, Rees BWG, Johnson AP, Elwood PC, Abemethy M. Food antibodies and myocardial infarction. Lancet 1974; i: 1012-14.
  • Toivanen A, Viljanen MK, Svilahti E. IgM and IgG anti-milk antibodies measured by radio-immunoassay in myocardial infarction. Lancet 1975; ii: 205-7.
  • Scott BB, Swinburne ML, McGuffin P, Losowsky MS. Dietary antibodies and myocardial infarction. Lancet 1976; ii: 125-6.
  • Gibney MJ, Gallagher PJ, Sharratt GP, Benning HS, Taylor TG, Pitts JM. Antibodies to heated milk protein in coronary heart disease. Atherosclerosis 1980; 37: 151-5.
  • Davies DF, Rees BWG, Davies PTG. Cows' milk antibodies and coronary heart disease. Lancet 1980; i: 1190-1.
  • Davies DF, Rees BWG, Davies PTG. Bovine milk fat globule and human platelets. Int Lab 1982; 12: 22-4.
  • Harrison R, Benboubetra M, Bryson S, Thomas RD, Elwood PC. Antibodies to xanthine oxidase: elevated levels in patients with acute myocardial infarction. Cardioscience 1990; 1: 183-9.
  • Oster KA. Xanthine oxidase. In: Freed DLJ (ed.) Health Hazards of Milk. London: Balliere-Tindall, 1984: 239-53.
  • Oster KA, Oster JB, Ross DJ. Immune response to bovine xanthine oxidase in atherosclerotic patients. Am Lab 1974; 6: 41-7.
  • Carr CJ, Talbot JM, Fisher KD. A review of the significance of bovine milk xanthine oxidase in the etiology of atherosclerosis. Bethesda, MD: FASEB Life Sciences Research Office; Contract No. FDA 223-75-2020 (Division of Nutrition, Bureau of Foods), 1975.
  • Walker WA, Isselbacher KJ. Uptake and transport of macromolecules by the intestine: possible role in clinical disorder. Gastroenterology 1974; 67: 531-50.
  • Rzucicflo SJ, Zikakis JP. Correlation of dairy food intake with human antibody to bovine milk xanthine oxidase. Proc R Soc Exp Biol Med 1979; 160: 477-82.
  • Paries DA, Granger DN. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand Suppl 1986; 548: 87-99.
  • Jarasch E-D, Bruder G, Heid HW. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand Suppl 1986; 548: 39-46.
  • Yamamoto T, Moriwaki Y, Takahashi S et al. Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography. J Chromatogr B 1996; 681: 395-400.
  • Shamma'a MH, Nasrallah SM, Al-Khalidi UAS. Serum xanthine oxidase. An experience with 2000 patients. Dig Dis 1973; 18: 15-22.
  • Miesel R, Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation 1993; 17: 551-61.
  • Tan S, Gelman S, Wheat JK, Parkes DA. Circulating xanthine oxidase in human ischemia-reperfusion. Southern Med J 1995; 88: 479-82.
  • Benboubetra M, Gleeson A, Harris CPD et al. Circulating anti-(xanthine oxidoreductase) antibodies in healthy human adults. Eur J Clin Invest 1997; 27: 611-19.
  • Lewis WHP, Ng YLE Human xanthine oxidase antibody levels: variation in males and females in Chinese and Europeans. Med Lab Sei 1991 ; 48: 84-8.
  • Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins and atherosclerosis : prevailing assumptions and outstanding questions. Am Heart J 1987; 114: 1467-503.
  • Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114: 413.
  • Gershon H. Is the sequestration of aged erythrocytes mediated by natural autoantibodies ? Israel J Med Sei 1992; 28: 818-26.
  • Clifford AJ, Ho CY, Swenerton H. Homogenized bovine milk xanthine oxidase: a critique of the hypothesis relating to plasmalogen depletion and cardiovascular disease. Am J Clin Nutr 1983; 38: 327-32.
  • Deeth HC. Homogenized milk and atherosclerotic disease: a review. J Dairy Sei 1983; 66: 1419-35.
  • Massey V, Harris CH. Milk xanthine dehydrogenase : the first one hundred years. Biochem Soc Trans 1997; 25: 750-5.
  • Green DE, Pauli R. The antibacterial action of the xanthine oxidase system. Proc Soc Exp Biol Med 1943; 54: 148-50.
  • Lipmann F, Owen CR. The antibacterial effect of enzymatic xanthine oxidation. Science 1943; 98: 246-8.
  • Bjorck L, Claesson O. Xanthine oxidase as a source of hydrogen peroxide for the lactoperoxidase system in milk. J Dairy Sci 1979; 62: 1211-15.
  • Stevens CR, Millar TM, Clinch JG, Kanczler JM, Bodamyali T, Blake DR. Antibacterial properties of xanthine oxidase in human milk. Lancet 2000; 356: 829-30.
  • Godber BLJ, Doel JJ, Sapkota GP et al. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem 2000; 275: 7757-63.
  • Godber BLJ, Doel JJ, Durgan J, Eisenthal R, Harriso n R. A new route to peroxynitrite : a role for xanthine oxidoreductase. FEBS Lett 2000; 475: 93-6.
  • Brunei! i L, Crow JP, Beckman JS. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coll. Arch Biochem Biophys 1995; 316: 327-34.
  • DeMoss JA, Hsu P-Y. NarK enhances nitrate uptake and nitrite excretion in Escherichia coli. J Bacteriol 1991; 173:3303-10.
  • Cole J. Nitrate reduction to ammonia by enteric bacteria: redundancy, or a strategy for survival during oxygen starvation? FEMS Microbiol Lett 1996; 136: 1-11.
  • Adachi T, Fukushima T, Usami Y, Hirano K. Binding of human xanthine oxidase to sulphated glycosylaminoglycan s on the endothelial cell surface. Biochem J 1993; 289: 523-7.
  • Nakamura M, Yamazaki I. Preparation of bovine milk xanthine oxidase as a dehydrogenase form. J Biochem 1982; 92: 1279-86.
  • Abadeh S, Killacky J, Benboubetra M, Harrison R. Purification and partial characterizatio n of xanthine oxidase from human milk. Biochim Biophys Acta 1992; 1117: 25-32.
  • Godber B, Sanders SA, Harrison R, Eisenthal R, Bray RC. > 95% of xanthine oxidase in human milk is present as the demolybdo form, lacking molybdopterin. Biochem Soc Trans 1997; 25: 519S.
  • Bray RC, Lowe D, Godber B, Harrison R, Eisenthal R. Properties of xanthine oxidase from human milk: the enzyme is grossly deficient in molybdenum and substantially deficient in iron-sulphur centres. In: Ghisla S, Cronack P, Macheroux P, Sund H (eds) Flavins and Flavoproteins. Berlin: Agency for Scientific Publications Rudolf Weber, 1999: 775-8.
  • Harrison R. Human xanthine oxidoreductase: in search of a function. Biochem Soc Trans 1997; 25: 786-91.
  • Brown A-M, Benboubetra M, Ellison M, Powell D, Reckless JD, Harrison R. Molecular activation-deactivation of xanthine oxidase in human milk. Biochim Biophys Acta 1995; 1245: 248-54.
  • Salisbury V, Pfoest A, Wiesinger-Mayer H, Lewis R, Bowker KE, MacGowan AP. Use of a clinical Escherichia cou isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxiflaxacin. J Antimicrob Chemother 1999; 43: 829-32.
  • Van den Munckhof RJM, Vreeling-Sindelarova HA, Schellens JPM, Van Noorden CJF, Frederiks WM. Ultrastructural localization of xanthine oxidase activity in the digestive tract of the rat. Histochem J 1995; 27: 897-905.
  • Kovar MG, Serdula MK, Marks JS, Fraser DW. Review of the epidemiologic evidence for an association between infant feeding and infant health. Pediatrics Suppl. 1984; 74: 615-38.
  • Beaudry M, Dufour R, Marcoux S. Relation between infant feeding and infections during the first six months of life. J Pediatr 1995; 126: 191-7.
  • Georgieff M, Piovanetti Y, Queenan J. Breast feeding and the use of human milk. Work group on breast feeding, American Academy of Pediatrics. Pediatrics 1997; 100: 1035-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.